139 related articles for article (PubMed ID: 3192050)
21. [Treatment of myelodysplastic syndromes].
Aul C; Heyll A; Gattermann N; Schneider W
Dtsch Med Wochenschr; 1987 Feb; 112(8):309-13. PubMed ID: 3469067
[No Abstract] [Full Text] [Related]
22. Myelodysplastic syndrome evolving into a myeloproliferative disorder: one disease or two?
Ohyashiki K; Yokoyama K; Kimura Y; Ohyashiki JH; Ito T; Kuratsuji T; Komatsumoto S; Nara M; Toyama K
Leukemia; 1993 Feb; 7(2):338-40. PubMed ID: 8426488
[TBL] [Abstract][Full Text] [Related]
23. Leukocyte alkaline phosphatase score correlation with bone marrow blast percentage in myelodysplastic syndrome.
Lipshitz J; Limaye S; Patel D
Acta Haematol; 2010; 124(3):179-81. PubMed ID: 20962518
[No Abstract] [Full Text] [Related]
24. CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes.
Baur AS; Meugé-Moraw C; Schmidt PM; Parlier V; Jotterand M; Delacrétaz F
Eur J Haematol; 2000 Feb; 64(2):71-9. PubMed ID: 10997326
[TBL] [Abstract][Full Text] [Related]
25. The prognostic significance of cytological, histological and cytogenetic findings in refractory anaemia (RA) and RA with sideroblasts. A follow up study.
Kerndrup G; Bendix-Hansen K; Pedersen B
Blut; 1987 Apr; 54(4):231-8. PubMed ID: 3828539
[TBL] [Abstract][Full Text] [Related]
26. [Myelodysplastic syndrome. Main symptoms: mostly nonspecific anemia symptoms].
Kolyvanos Naumann U; Nigg C; Käser L; Vetter W
Praxis (Bern 1994); 2005 Jul; 94(28-29):1095-100; quiz 1101. PubMed ID: 16078749
[No Abstract] [Full Text] [Related]
27. [Clinical picture and diagnosis of refractory anemia with an excess of blasts and with bone marrow hypoplasia].
Gladysh VV; Turbina NS; Mikhaĭlova EA; Ustinova EN; Pylaeva NN
Gematol Transfuziol; 1989 Jul; 34(7):6-10. PubMed ID: 2792720
[TBL] [Abstract][Full Text] [Related]
28. The myelodysplastic syndromes: diagnostic criteria and laboratory evaluation.
Ho PJ; Gibson J; Vincent P; Joshua D
Pathology; 1993 Jul; 25(3):297-304. PubMed ID: 8265251
[No Abstract] [Full Text] [Related]
29. [Myelodysplastic syndromes].
Ann Biol Clin (Paris); 1985; 43(4):369-79. PubMed ID: 4091300
[No Abstract] [Full Text] [Related]
30. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).
Omine M; Yamauchi H
Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):800-10. PubMed ID: 2618556
[TBL] [Abstract][Full Text] [Related]
31. [Myelodysplastic syndromes--from FAB to WHO classification].
Kotlarek-Haus S; Haus O
Pol Arch Med Wewn; 2005 Nov; 114(5):1128-37. PubMed ID: 16789514
[No Abstract] [Full Text] [Related]
32. Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome.
Knipp S; Strupp C; Gattermann N; Hildebrandt B; Schapira M; Giagounidis A; Aul C; Haas R; Germing U
Leuk Res; 2008 Jan; 32(1):33-7. PubMed ID: 17412418
[TBL] [Abstract][Full Text] [Related]
33. Marked decreases of total and immature reticulocytes in myelodysplastic syndrome among patients with pancytopenia.
Kabutomori O; Kanakura Y; Iwatani Y
Acta Haematol; 2003; 109(4):212-3. PubMed ID: 12853698
[No Abstract] [Full Text] [Related]
34. [A 57-year-old patient with peripheral pancytopenia].
Fink M; Prenninger S; Sauer H
Internist (Berl); 1989 Mar; 30(3):210-3. PubMed ID: 2654063
[No Abstract] [Full Text] [Related]
35. What is in a name? Refined diagnostic criteria for prognostic assessment in myelodysplastic syndrome (MDS).
Deeg HJ
Leuk Res; 2004 Jun; 28(6):543-4. PubMed ID: 15120927
[No Abstract] [Full Text] [Related]
36. [Myelodysplastic syndrome classification].
Ghariani I; Braham N; Hassine M; Kortas M
Ann Biol Clin (Paris); 2013; 71(2):139-44. PubMed ID: 23587576
[TBL] [Abstract][Full Text] [Related]
37. Serum erythropoietin (EPO) levels correlate with survival and independently predict response to EPO treatment in patients with myelodysplastic syndromes.
Wallvik J; Stenke L; Bernell P; Nordahl G; Hippe E; Hast R
Eur J Haematol; 2002 Mar; 68(3):180-5. PubMed ID: 12068800
[TBL] [Abstract][Full Text] [Related]
38. Percentages of bone marrow blasts and chromosomal changes in patients with refractory anemia help to determine prognoses.
Iwabuchi A; Ohyashiki K; Ohyashiki JH; Kimura Y; Lin KY; Aizawa S; Nehashi Y; Miyazawa K; Yaguchi M; Toyama K
Int J Hematol; 1994 Oct; 60(3):207-13. PubMed ID: 7858240
[TBL] [Abstract][Full Text] [Related]
39. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome.
Suciu S; Kuse R; Weh HJ; Hossfeld DK
Cancer Genet Cytogenet; 1990 Jan; 44(1):15-26. PubMed ID: 2293879
[TBL] [Abstract][Full Text] [Related]
40. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
